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Rates of self-harm have shown a steady increase in recent years,
particularly in men.1 Self-harm is the most important risk factor
for suicide2–4 and the risk of suicide is further increased among
those who self-harm repeatedly, particularly among females.5
Rates of repeated self-harm are significant and increasing.6 Yet
there has been a lack of research evidence of effective treatment
interventions for self-harm,7,8 which limits the power of treatment
guidelines.9,10 Poorer problem-solving ability has been found
among people engaging in self-harm,11–15 particularly those who
self-harm repeatedly.16–18 There is substantial evidence that
problem-solving ability mediates the relationship between stress
and self-harm, whereby individuals with poor problem-solving
ability under chronic stress are more likely to become hopeless
and/or suicidal.19–22 Evidence also suggests that good problem-
solving protects against self-harm, independently of depression
or hopelessness levels.16 Among people who self-harm, coping
responses characterised by greater passivity and avoidance are
associated with an increased risk of repeated self-harm.18
Promising results have been found for problem-solving
therapy in reducing repetition of self-harm.7–8,23 In an early study
of interpersonal problem-solving skills training, 39 patients who
had self-poisoned were randomly assigned to five sessions of
individual interpersonal problem-solving skills training or to a
brief problem-oriented approach. Although similar improvements
were found in levels of hopelessness and presenting problems for
both treatment conditions, those assigned to interpersonal
problem-solving skills training had a lower rate of repetition at
12-month follow-up compared with the control group.24 The
difference in repetition between treatment groups was not
statistically significant however as, like many of the early trials,
the sample size was too small. A later trial involving 120 adults
who had recently self-harmed reported a significantly lower
repetition rate among those assigned to a cognitive therapy arm
comprising ten out-patient cognitive therapy sessions that
included a problem-solving component, compared with usual
care.25 The investigators also reported a significant improvement
in self-reported levels of depression and hopelessness, but there
was no difference between treatment conditions on rates of
suicidal ideation. Generalisation of the study outcomes is difficult
because of the high self-harm repetition rate in the control group.
Another trial26 examined a 12-session cognitive–behavioural
therapy (CBT) programme with 90 adolescents and young adults
(aged 15–35 years) who had recently engaged in self-harm. The
programme was based on a model of maintenance factors of
self-harm drawing on the assumption that they can be modified
by adjusting negative thinking and problem-solving deficits. The
authors reported a significant reduction in repetition of self-harm
in the CBT group. Even though the study outcomes support the
efficacy of brief CBT for self-harm, it is not clear whether the
outcomes can be generalised because of the relatively young target
population and the pattern of frequent self-harm repetition prior
to enrolment in the study. The failure of an earlier trial using a
manual-assisted cognitive therapeutic approach to demonstrate
a reduction in repeat episodes,27 in which over a third of the active
treatment sample received a treatment manual alone without any
treatment sessions, suggests that reliance purely on a self-help
approach among repeaters of self-harm is ineffective in reducing
repetition.28Again, generalisation of the study outcomes was
hampered by only including patients with a history of self-harm
acts.
In the present study, the effectiveness of a brief group
problem-solving skills training (PST) programme for self-harm
was examined among both younger and older adults who have
self-harmed, and including those with and without a history of
self-harm. When the PST programme was previously compared
against standard care in the treatment of individuals who have
self-poisoned using individual psychotherapy, lower rates of
repeated self-harm were reported in the PST group.24 The
intervention was based on a problem-solving model of self-harm
and its repetition, originally developed for the treatment of
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Background
Rates of self-harm are high and have recently increased.
This trend and the repetitive nature of self-harm pose a
significant challenge to mental health services.
Aims
To determine the efficacy of a structured group problem-
solving skills training (PST) programme as an intervention
approach for self-harm in addition to treatment as usual
(TAU) as offered by mental health services.
Method
A total of 433 participants (aged 18–64 years) were randomly
assigned to TAU plus PST or TAU alone. Assessments were
carried out at baseline and at 6-week and 6-month follow-up
and repeated hospital-treated self-harm was ascertained at
12-month follow-up.
Results
The treatment groups did not differ in rates of repeated self-
harm at 6-week, 6-month and 12-month follow-up. Both
treatment groups showed significant improvements in
psychological and social functioning at follow-up. Only one
measure (needing and receiving practical help from those
closest to them) showed a positive treatment effect at 6-
week (P=0.004) and 6-month (P=0.01) follow-up. Repetition
was not associated with waiting time in the PST group.
Conclusions
This brief intervention for self-harm is no more effective than
treatment as usual. Further work is required to establish
whether a modified, more intensive programme delivered
sooner after the index episode would be effective.
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depression.29 Compared with treatment as usual (TAU) alone, the
PST programme was expected to be significantly more effective in:
(a) reducing the rate of repetition of self-harm and suicidal
ideation; (b) improving psychological and social functioning as
assessed by standardised measures of interpersonal problem-
solving skills, self-efficacy and perceived social support; and (c)
reducing levels of depression, anxiety, hopelessness and impulsivity.
Method
Design
Following initial assessment, participants were randomly assigned
to treatment conditions on the basis of a computer-generated
sequence of numbers. Allocation was concealed using sealed
opaque envelopes. Randomisation was stratified according to the
gender and repeater status of participants as well as the study site
at which participants were recruited. Participants were randomly
assigned to either six sessions of group PST in addition to TAU
(standard care) as offered by mental health services or to TAU
only. The trial was approved by the clinical research ethics
committee of the Cork University Teaching Hospitals and the
HSE Mid-Western Area Regional Ethics Committee.
Participants
Consecutive patients aged 18–64 were included in the trial if,
during the previous 3 days, they had engaged in self-harm defined
according to the definition devised by the World Health
Organization (WHO) Working Group of the WHO/EURO
Multicentre Study on Suicidal Behavior as ‘an act with non-fatal
outcome, in which an individual deliberately initiates a non-
habitual behaviour that, without intervention from others, will
cause self-harm, or deliberately ingests a substance in excess of
the prescribed or generally recognized therapeutic dosage, and
which is aimed at realizing changes which the subject desired
via the actual or expected physical consequences’.30 All
participants received a psychiatric review by a liaison psychiatrist
in line with standard practice in all recruiting emergency
departments and acute psychiatric units. On the basis of the
psychiatric review notes, patients were excluded from the trial if
they had a history of psychosis, intellectual disability, sensory
disability or organic cognitive impairment; were currently alcohol
or drug dependent; were in prison at the time of the episode; or
were not living at a fixed abode. The baseline assessment schedule
included the Short Alcohol Dependent Data questionnaire
(SADD),31 a 15-item measure of present state dependence among
adults. Only those with a diagnosis of alcohol or drug dependence
or who scored above the cut-off for dependence on the SADD
were excluded.
Recruitment was conducted at two trial sites (Cork and
Limerick) between November 2001 and March 2005. The Cork
site comprised the emergency departments of Cork University
Hospital, Mercy University Hospital and South Infirmary-Victoria
University Hospital and the acute psychiatric units at Cork
University Hospital and Mercy University Hospital. The Limerick
site comprised the emergency department and the acute
psychiatric unit at the Mid-Western Regional Hospital. The trial
was stopped when the target number was reached. After trial
commencement the eligibility criteria were broadened to include
patients self-harming on acute psychiatric units (with or without
presentation to the emergency department) at the recruiting
hospitals in order to increase recruitment.
Procedure
At each of the recruitment centres, informed written consent was
obtained by trained research officers from eligible patients who
had engaged in self-harm within the previous 3 days prior to
initial assessment and randomisation. Participants were then
assessed either at the recruitment site or at home using a
structured assessment schedule. The first section, which assessed
characteristics of the index episode and symptoms, was administered
within 3 days of the index episode. Where possible, the remainder
of the schedule was administered at the same time but where
circumstances did not allow for this, arrangements were made
to complete the assessment within 2 weeks of the index episode.
Psychological, behavioural and social characteristics of participants
were assessed at baseline, 6-week (i.e. post-treatment) and 6-month
follow-up, using the instruments outlined in Appendix 1.
As part of the consent sought, all participants were encouraged
to identify a significant other (for example a friend or family
member) who would support their initial connection with the
programme. Following randomisation, significant others were
informed by letter that they had been nominated to support
involvement in the treatment programme (PST or TAU groups)
and were encouraged to do so in practical ways such as transport
to treatment sessions or through moral support and encouragement.
Following recruitment all participants (PST and TAU groups) were
contacted by telephone on a weekly basis to minimise pretreatment
attrition.
Six-week follow-up
At the end of treatment (following completion of each PST
group programme), participants in both groups completed a
post-assessment schedule, which was broadly similar to the
baseline assessment (Appendix 1).
Six-month follow-up
Six months after the treatment ended, participants in both groups
completed a shortened version of the post-assessment schedule
(Appendix 1).
Twelve-month follow-up
For all 433 participants, researchers, masked to participant
treatment allocation, manually checked the emergency department
records of local hospitals in order to identify presentations as a
result of repeated self-harm in the 12-month period after
participants’ index acts.
Outcome measures
The primary outcome measure was the proportion of participants
in each group who repeated self-harm during the follow-up
period. At 6-week and 6-month follow-up, this was assessed by
self-report of any repeated self-harm (whether hospital treated
or not), whereas at 12-month follow-up the outcome was based
on repeated self-harm leading to hospital presentation. Although
there was no centralised mechanism for identifying cases of
suicide, those detected via hospital records were included in the
12-month follow-up. Secondary outcome measures included
suicidal ideation, depression, hopelessness, anxiety, impulsivity,
self-efficacy, problem-solving (process and outcome measures)
and social life (Appendix 1).
Intervention
Problem-solving skills training
The PST programme (B. McLeavey, personal communication, 2001)
consisted of six 2 h closed group sessions, held weekly, of structured,
manualised interpersonal problem-solving skills training, facilitated
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by a trained therapist and a co-therapist. A ‘Practice at Home
Journal’ was provided for participants to carry out homework
assignments using their own interpersonal problems (B. McLeavey,
personal communication, 2001). Treatment fidelity was ensured
by strict adherence to the skills training manual, completion of
a session-adherence self-report worksheet by therapists at the
end of each weekly session and weekly supervision by a research
psychologist who had delivered the training to the therapists.
Supervision included screening of session-adherence self-report
worksheets. The programme was held in a central community-
based venue in both trial sites (Cork and Limerick). To minimise
attrition rates, problem-solving therapists made routine between-
session telephone calls to participants in the PST group to remind
them of the date and time of their next appointment.
Treatment as usual
Treatment as usual involved assessment by mental health
professional staff and by crisis nurses. Psychosocial assessment
of all patients was carried out by a psychiatrist (liaison psychiatry
or mental health team) to determine mental health needs and level
of risk to self or others. Patients who had no contact with mental
health services during the previous year and not requiring referral
on to mental health acute or community-based services were
referred to the crisis nurse service for further psychosocial
assessment and suicide risk assessment. A collaborative
management plan of care, including a problem-solving approach
and relapse prevention techniques, was agreed between the crisis
nurse and the patient. Those who were referred on by the
psychiatrist to mental health acute or community-based services
were commonly offered pharmacological treatment and review
by the mental health team and less frequently counselling or
psychotherapy.
Power analysis
Based on the power calculation, 219 participants were required in
each treatment condition of the trial in order for the study to have
80% power to identify a reduction from 20% to 10% in the
proportion who repeated self-harm as being statistically significant
at the 5% significance level. The expected effect was based on an
earlier smaller trial of problem-solving therapy in the same setting
in which the rate of repeated self-harm among those assigned to
PST was 11% at 12 months v. 25% among those assigned to
standard care.24
Statistical analysis
For the primary outcome measure (repeated self-harm), separate
binary regression models were estimated for each follow-up period.
These models were estimated for participants who provided self-
report data on the outcome measure at 6-week (313 of 354) and
6-month (234 of 326) follow-up. The model for the outcome of
hospital-treated repeated self-harm was based on all 433 participants.
The covariates included were the treatment condition and whether
the participant had a history of self-harm prior to the index act.
For the PST group the association between the waiting time (time
from the index episode to starting PST) and repeated self-harm
was examined using a binary regression that included the log-
transformed waiting time and history of self-harm prior to the
index episode.
For each of the other outcome measures, treatment effect (PST
v. TAU) was estimated using a linear mixed-effects model,32 which
utilised all available data from baseline and follow-up. Treatment
effect was not assessed for the problem-solving skills measures,
Means-Ends Problem-Solving Procedure (MEPS)33 and the
Optional Thinking test (OT),34 as these measures were only
assessed at 6-week follow-up and were incomplete for 45% of
participants. The linear mixed-effects models included a random
intercept to allow for correlations between repeated measures on
the same individual. The covariates included were the treatment
condition, follow-up period and the interaction of treatment
condition and follow-up period. The interaction term allows
the effect of treatment to differ between 6-week and 6-month
follow-up. Data were analysed using Stata version 12.1 for Windows.
Results
During the recruitment phase, 2661 patients presenting with self-
harm were screened for the trial (Fig. 1). Over half of the patients
screened (1527, 57%) were ineligible. Reasons for ineligibility
included being alcohol dependent (16%), outside the age range
(13%), with a current or previous psychosis (8%), living outside
the trial area (7%), drug dependent (3%), not medically fit within
the required time to complete the initial assessment (2%), of no
fixed abode (2%) and having an intellectual disability (1%). Of
the 1134 eligible patients (43%), 433 (38%) were randomised
whereas 701 (62%) refused to participate. Most of the 433
participants (313, 72%) were recruited from the local hospital
emergency departments and the remaining 120 (28%) were
recruited from acute mental health in-patient units. A total of
222 patients were randomised to group problem-solving skills
training (PST group) and 211 were randomised to treatment as
usual (TAU group). The median length of time from index episode
to starting PST was 40 days.
Baseline characteristics of participants in each treatment
group are reported in Table 1. Participants assigned to TAU
(n=211) were similar to those in the PST group (n=222) with
regard to all measures. A higher proportion of those assigned to
TAU had self-harmed using an overdose at index episode.
Outcome measures at baseline, post-assessment
and follow-up
The treatment groups did not differ in rates of repeated self-harm
at 6-week, 6-month and 12-month follow-up (Table 2). Similar
numbers of repeat presentations to hospital were recorded for
participants in both treatment conditions in the 12 months
following the index presentation. For the 54 of the 222 participants
assigned to PST who made a repeat self-harm presentation to
hospital, 38 (70.4%) represented once, 9 (16.7%) represented
twice, 2 (3.7%) represented 3 times, 3 (5.6%) represented 4 times,
1 (1.9%) represented 8 times and 1 (1.9%) represented 13 times.
For the 50 of the 211 participants assigned to TAU who represented
because of self-harm, 30 (60.0%) represented once, 10 (20.0%)
represented twice, 3 (6.0%) represented 3 times, 3 (6.0%)
represented 4 times, 3 (6.0%) represented 5 times and 1 (2.0%)
represented 18 times. Three participants were known, based on
hospital records, to have died by suicide during the 12-month
follow-up period (two in the TAU group and one in the PST
group). Repetition was not associated with waiting time in the
PST group.
Compared with those in the TAU group, participants in the
PST group did not show a significantly different change on any
of the secondary outcome measures at 6-week or 6-month
follow-up, with the exception of the Practical Support subscale
from the Social Life Scale35,36 on which there was a positive
treatment effect at 6 weeks (P=0.004) and at 6 months
(P=0.01). The Practical Support subscale is a measure of the
extent to which a person needs practical help and receives
practical help from the person closest to them.
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Drop-out rates
There was a significant difference in the rate of drop-out from the
trial (in terms of those failing to present at follow-up) between the
two groups. Drop-out rates were higher in the TAU group 23% v.
14% in the PST group (P= 0.009) at 6-week assessment and 30%
in the TAU group v. 20% in the PST group (P= 0.02) at 6-month
follow-up. There was no difference in baseline measurement
between those who attended the 6-week assessment and those
who did not, with the exception of scores on the Beck Anxiety
Inventory40 (mean 23.5 v. 26.8 respectively, P= 0.04). There was
no difference in baseline measurements between those who
attended the 6-month follow-up and those who did not.
Adherence with group interpersonal problem-solving
skills training
A relatively high rate of adherence to treatment was found among
those assigned to PST. Almost half of those assigned to PST (103,
46.4%) attended all 6 therapy sessions. Over two-thirds of those
assigned to PST (153, 68.9%) attended three or more treatment
sessions. Most of the attrition occurred prior to the patients’ first
session, with 43 patients (19.4%) failing to attend any sessions.
When adherence was examined among those who attended at least
one treatment session, 103 (57.5%) of patients attended all six
sessions and 153 (85.5%) attended three or more PST sessions.
Unfortunately, as a result of the wide range of treatments received
by those assigned to TAU and the wide range of settings in which
these treatments were delivered it was not possible to ascertain
adherence to treatment for this group.
Discussion
Main findings
The brief group problem-solving skills training programme
described was designed to enhance standard care following an
episode of medically treated self-harm. The main trial hypothesis,
that PST in addition to standard care would be significantly more
effective in reducing repetition of self-harm than TAU alone, was
not supported. Compared with TAU alone, those who received
PST in addition to standard care did not show significantly greater
improvement in psychological and social functioning or significantly
greater reductions in depression, anxiety, hopelessness or impulsivity.
In fact, no significant differences were found between participants
in the PST and TAU condition on any of the outcome measures
examined except the Practical Support subscale of the Social Life
Scale35,36 on which participants in the PST condition showed a
significantly greater improvement at 6 weeks and at 6 months.
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Available patients who self-harm
n=2661
Not eligible for inclusion
n=1527 (57%)
Alcohol dependence (n=426)
Age outside range (n=356)
Diagnosis psychosis (n=216)
Outside trial area (n=181)
Drug dependence (n=79)
Not medically fit (n=64)
No fixed abode (n=62)
Intellectual disability (n=35)
Sensory disability (n=6)
Miscellaneous (n=102)
Eligible for inclusion
n=1134 (43%)
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n=433 (38%)
Group interpersonal
problem-solving therapy
n=222
6-week follow-up
n=192
6-month follow-up
n=178
Treatment as usual
n=211
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6-month follow-up
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Fig. 1 Flow of participants through the trial.
Table 1 Baseline characteristics of participants receiving
group problem-solving therapy (PST) and treatment as
usual (TAU)
Characteristic
PST group
(n=222)
TAU group
(n=211)
Female, % 64 65
Age, years: mean (s.d.) 33.4 (11.5) 33.6 (12.1)
Marital status, %
Single/cohabiting 59 59
Married 28 25
Widowed 13 14
Divorced 0.5 1.5
Employed, %
Employed (full/part-time) 52 57
Unemployed 17 20
Disabled 8 8
Student 11 5
Home duties 12 9
Retired 2 1
Education, %
Primary 13 16
Junior Certificate 24 30
Leaving Certificate 35 34
Third levela 28 20
Previous self-harm, yes: % 64 63
Index method, %
Self-poisoning 76 85
Self-cutting 20 17
Hanging 6 4
Drowning 6 4
Other 2 2
Suicidal ideation, mean (s.d.) 12.8 (11.2) 12.4 (11.4)
Depression, mean (s.d.) 35.8 (13.4) 36.3 (13.6)
Hopelessness, mean (s.d.) 10.9 (5.7) 10.6 (6.1)
Anxiety, mean (s.d.) 23.5 (12.9) 24.7 (13.3)
Impulsivity, mean (s.d.) 73.2 (13.7) 76.1 (12.0)
Self-efficacy, mean (s.d.) 22.7 (6.3) 23.0 (7.1)
Self-rated problem-solving, mean (s.d.) 70.6 (11.8) 70.4 (12.2)
Means-ends problem-solving (MEPS),
median (Q1, Q3)
0.40 (0, 0.86) 0.25 (0, 0.80)
Optional thinking (OT), median (Q1, Q3) 0.67 (0.33, 0.75) 0.67 (0.33, 0.80)
Social Life Scale,35,36 mean (s.d.)
Confiding/emotional 8.2 (2.4) 8.4 (2.6)
Practical support 4.8 (2.0) 5.1 (2.0)
Negative 12.2 (3.0) 12.6 (3.3)
a. Includes university, college, technical training institute, institutions of higher
education and institutions that provide vocational education and training.
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Participants in both the PST and TAU groups showed significant
improvements on most outcome measures. In both groups,
participants improved significantly on 9 out of 11 outcome
measures comparing baseline to 6-week follow-up. At 6-month
follow-up no further significant changes were observed for these
outcome measures, indicating that improvements made in both
treatment conditions were maintained over time.
Practical problems with the implementation of design
and lack of differential treatment effects
The theoretical model underlying the experimental treatment
(PST) condition was that the development of improved inter-
personal problem-solving skills in participants would lead to
reduced vulnerability to repeated self-harm. Although significant
improvements were found in these skills among participants in
both groups, no significant differences were found between those
in the PST group and those in the TAU group on any of the
outcome measures of problem-solving at 6-week or 6-month
follow-up. Several procedural aspects of the trial may have had a
therapeutic effect on the patient’s condition and therefore may
have contributed to the lack of differential treatment outcomes
between the groups. As described earlier, participants in both
the PST and TAU groups were encouraged to identify a significant
other (for example a friend or family member) who would
support their initial connection with the treatment programme.
Following randomisation, significant others (PST and TAU
groups) were informed by letter that their relative or friend had
nominated them as their significant other to support their
involvement in the treatment programme. Following recruitment,
all participants (PST and TAU groups) were contacted by telephone
on a weekly basis to minimise pretreatment attrition. The
participants themselves were also notified by telephone and by
letter of their treatment allocation. Initial and follow-up assess-
ments provided participants in both groups with the opportunity
to discuss problems. In cases where participants were discharged
from hospital prior to completion of initial assessment and where
they could not make their way to the venue for follow-up
assessment, home visits were arranged by the researcher. It could
be argued that this may have obfuscated differences between the
treatment conditions. The possible therapeutic effects of these
active intervention aspects should not be underestimated. For
example, in an earlier trial by Carter and colleagues44 the number
of repeat self-harm episodes was significantly reduced in those
who received a minimal intervention (eight postcards posted to
medically treated individuals who had self-poisoned over a
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Table 2 Change in outcome measures and treatment effect at follow-upa
Group
Problem-solving skills
training (PST) (n= 222)
Treatment as usual (TAU)
(n= 211) Mean (95% CI)b P
Repeated self-harm during follow-up, %
At 6 weeks (n=313) 13.5 19.0 0.71 (0.43 to 1.18) 0.19
At 6 months (n= 234) 30.5 24.5 1.23 (0.81 to 1.87) 0.33
At 12 months (n= 433)c 24.3 23.7 1.02 (0.73 to 1.42) 0.92
Scales, mean (95% CI), P
Beck Scale for Suicidal Ideation37 (n= 424)
Change at 6 weeks 78.4 (710.1 to 76.7), <0.001 76.3 (78.1 to 74.5), <0.001 72.1 (74.5 to 0.4) 0.09
Change at 6 months 78.3 (79.9 to 76.6), <0.001 77.4 (79.3 to 75.6), <0.001 70.8 (73.3 to 1.6) 0.51
Beck Depression Inventory38 (n= 433)
Change at 6 weeks 717.5 (720.2 to715.4), <0.001 716.3 (718.8 to 713.7), <0.001 71.5 (75.0 to 2.0) 0.40
Change at 6 months 718.3 (720.8 to715.8), <0.001 717.5 (720.1 to 714.9), <0.001 70.8 (74.4 to 2.8) 0.67
Beck Hopelessness Scale39 (n= 433)
Change at 6 weeks 74.1 (75.1 to 73.1), <0.001 73.3 (74.4 to 72.3), <0.001 70.7 (72.2 to 0.7) 0.32
Change at 6 months 73.8 (74.8 to 72.8), <0.001 73.4 (74.5 to 72.3), <0.001 70.4 (71.9 to 1.1) 0.58
Beck Anxiety Inventory40 (n= 432)
Change at 6 weeks 79.4 (711.3 to 77.4), <0.001 78.1 (710.1 to 76.0), <0.001 71.3 (74.1 to 1.5) 0.37
Change at 6 months 79.7 (711.6 to 77.8), <0.001 78.7 (710.7 to 76.5), <0.001 71.0 (73.9 to 1.8) 0.48
Barratt Impulsivity Scale41 (n= 414)
Change at 6 weeks 71.0 (72.7 to 0.8), 0.27 72.6 (74.4 to 70.8), 0.01 1.7 (70.9 to 4.2) 0.20
Change at 6 months 71.7 (73.5 to 0.1), 0.06 73.4 (75.3 to 71.4), <0.001 1.6 (71.0 to 4.2) 0.23
Generalised Self-efficacy Scale42 (n= 431)
Change at 6 weeks 3.2 (2.2 to 4.2), <0.001 2.2 (1.1 to 3.2), <0.001 1.1 (70.4 to 2.6) 0.16
Change at 6 months 3.7 (2.7 to 4.8), <0.001 2.7 (1.6 to 3.8), <0.001 1.0 (70.5 to 2.5) 0.20
Self-Rating Problem-Solving Scale43 (n= 432)
Change at 6 weeks 8.1 (6.1 to 10.1), <0.001 6.0 (3.8 to 8.3), <0.001 2.1 (70.9 to 5.1) 0.17
Change at 6 months 8.6 (6.6 to 10.7), <0.001 7.7 (5.4 to 10.0), <0.001 0.9 (72.1 to 4.0) 0.55
Social Life Scale: confiding/emotional35,36 (n= 404)
Change at 6 weeks 70.8 (71.2 to 70.3), <0.001 70.5 (71.0 to 0.0), 0.03 70.3 (70.9 to 0.4) 0.45
Change at 6 months 70.8 (71.2 to 70.3), <0.001 70.6 (71.1 to 70.1), 0.02 70.2 (70.8 to 0.5) 0.66
Social Life Scale: practical support35,36 (n= 403)
Change at 6 weeks 0.1 (70.3 to 0.4), 0.74 70.7 (71.1 to 70.3), <0.001 0.8 (0.3 to 1.3) 0.004
Change at 6 months 70.1 (70.5 to 0.3), 0.55 70.8 (71.3 to 70.4), <0.001 0.7 (0.2 to 1.3) 0.01
Social Life Scale: negative35,36 (n= 403)
Change at 6 weeks 1.0 (0.5 to 1.5), <0.001 0.2 (70.3 to 0.8), 0.40 0.7 (0.0 to 1.5) 0.06
Change at 6 months 1.3 (0.8 to 1.8), <0.001 0.9 (0.3 to 1.5), 0.004 0.4 (70.4 to 1.2) 0.35
a. n refers to the number of participants whose data were used in the analysis.
b. For repeated self-harm during follow-up the figures given in this column are risk ratio (95% CI).
c. Repeated self-harm leading to hospital presentation within 12 months of the index episode based on manual checks of hospital emergency department records by researchers
masked to participant treatment allocation.
Treatment effect, PST v. TAU
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12-month follow-up period). Like Carter and colleagues however,
the design of the present trial does not allow us to examine the
possible mechanism of action of these additional interventions.
It can also be argued that the possible therapeutic effects of these
procedural aspects occurred in both treatment conditions, which
although making them more similar probably did not influence
the likelihood of finding a differential treatment effect of the active
treatment condition.
Strengths and limitations
Strengths of this trial include the large sample size and assessment
of the primary outcome measure (repeated self-harm) from both
participants’ self-report and researchers’ independent ascertainment.
Although significant improvements in outcome measures at
follow-up were found among patients in both groups and a
number of explanations can be offered for the lack of differences
in outcomes between PST and TAU, additional limitations of the
trial merit attention.
Differential drop-out rates
The significantly greater drop out at post-assessment and follow-up
of participants assigned to TAU may have masked important
differences in treatment outcome at both follow-up periods. Those
who failed to attend the 6-week follow-up had significantly higher
levels of anxiety at baseline assessment suggesting that they may
have been more unwell at follow-up. However, we carried out
analyses that included adjustment for baseline values and the
findings were highly consistent with those reported in the paper.
Duration, format and waiting time
A brief group-based interpersonal problem-solving skills training
intervention delivered over six sessions may not have been
sufficient to significantly reduce repetition among the group of
individuals who self-harmed included in the present trial, of whom
the majority had a history of self-harm episodes and scored within
the severe range on level of depression. The brief interventions tested
in trials with patients who have self-harmed (published after our
trial commenced) typically include 10–12 treatment sessions.25,26
Furthermore, the PST intervention of 6 weeks duration may have
been too brief to teach patients skills to interrupt repetition, when
considered in the context of the high risk of repetition for the first
12 months following the index episode. This is further supported
by negative outcomes of a brief manual-assisted CBT intervention
(maximum seven sessions) for patients who had self-harmed, all of
whom had a history of self-harm acts.27 In contrast, an earlier trial
using a brief 12-session CBT intervention lasting approximately 5.5
months, showed positive treatment effects on self-harm repetition
and relatedmental health outcomes favouring the CBT intervention.26
Another possible explanation for the lack of differential
treatment effects is the group format of the PST programme. A
recent review of cognitive–behavioural interventions to reduce
suicidal behaviour found that trials where one-to-one CBT was
included, and also trials combining individual and group
treatment, showed a very significant effect on repetition, whereas
studies using group therapy alone did not.23
A further important limitation arising from the implementation
of a randomised controlled trial investigating group therapy is the
potentially significant delay between recruitment and treatment
initiation. In the present trial the median length of time
between index episode and first PST session was 40 days. Although
we found no association with repetition, this almost certainly
contributed to the significant attrition prior to PST commencement.
Perhaps more importantly this considerable window of time
meant that pragmatic measures taken to minimise attrition for
all patients (PST and TAU groups) including weekly telephone
calls and encouragement from a significant other are likely to have
had important treatment effects in both groups and may also
explain the lack of differential treatment effects. The clinical
profile of participants in the present trial indicates a group that
requires more intensive input (incorporating one-to-one and
group therapy sessions and long-term treatment approaches), to
address patterns of frequent self-harm repetition associated with
comorbid psychological and psychiatric problems.25,26 Many of
the patients who completed the PST intervention indicated the
need for more than six treatment sessions, which further supports
this explanation. Put more simply the experimental treatment
programme in the present trial (PST), may have provided patients
with too little too late.
Eligibility
The most common reason for ineligibility for the trial was alcohol
dependence followed by age that was outside the trial age range.
Together these comprised half of those excluded from the trial.
Given the high risk of repetition among those misusing alcohol45
and the high rates of self-harm among girls aged 15–19 years in
particular,1 this trial failed to evaluate the efficacy of problem-
solving skills training in reducing repetition in these subgroups.
Clinical implications
Our findings indicate that for individuals who self-harm, the
majority of whom have a history of self-harm, a brief group
problem-solving skills training programme is no more effective
than TAU when delivered a median of 40 days following the index
episode. In clinical practice this time delay to therapy group
initiation would likely be halved as the constraint of
randomisation of eligible patients in a parallel trial would be
absent. Future trials might reduce potential delays to treatment
initiation by broadening the inclusion criteria further, for example
time from index episode to initial assessment could be extended
up to 1 week. Patients with a history of psychosis but not currently
psychotic could also be included. Additional measures to
minimise the wait to commence therapy could include offering
an initial one-to-one primer session with an overview of the
PST programme material or by running the six-session PST
programme as a semi-closed rather than a fully closed group on
a repeat basis, with each patient repeating the treatment
programme over 11 weeks, which could significantly shorten the
waiting time. Further work is required to establish whether a
modified, more intensive group problem-solving skills training
programme delivered sooner following the index episode would
be effective.
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Appendix
Overview of instruments used to assess
psychological, behavioural and social characteristics
assessed at baseline, 6-week post-assessment
and 6-month follow-up
Baseline 6 weeks 6 months
Suicide Intent Scale (SIS)46 [a – –
Beck Scale for Suicidal Ideation (BSS) [a [ [
Beck Depression Inventory (BDI) [a [ [
Beck Anxiety Inventory (BAI) [a [ [
Barratt Impulsivity Scale (BIS) [ [ [
Generalised Self-efficacy Scale (GSS) [ [ [
Means-Ends Problem-Solving
Procedure (MEPS) [ [ –
Optional Thinking Test (OT) [ [ –
Self-Rating Problem-Solving
Scale (SRPS) [ [ [
Current Problems List43 [ [ [
Beck Hopelessness Scale (BHS) [a [ [
Social Life Scale [ [ [
a. Denotes instruments that were administered at baseline within 3 days of the
index episode.
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When a psychiatrist is a patient
Aashish Tagore
I am proud to be a psychiatrist. Despite often feeling stigmatised by medical colleagues, I have always derived a great sense of
personal reward and satisfaction from my chosen line of work. As psychiatrists, we try to understand how it must feel for our
patients, and we strive to treat them with compassion, empathy and humanity. But what happens when you suddenly find yourself
on the other side of the fence?
Last year, after a traumatic event, I started experiencing persecutory delusions and was convinced that my life was in grave danger.
A descent into full-blown paranoid psychosis ensued, culminating in a hospital admission and treatment with antipsychotic
medication.
I was a patient on a ward on which I used to work – my worst nightmare realised. Not only was I embarrassed to be there, the staff
with whom I used to work appeared equally embarrassed for me. The pity was written all over their faces. And my own prejudice
towards mentally ill patients surfaced. Despite needing acute assessment and treatment, I felt I was for some reason better than or
at least different to them. I wanted to distance myself from them – to reassure myself that I was not one of them. But, alas, I was.
I was just as unwell, and just as human. I was just as vulnerable and susceptible to mental illness, just as breakable. I was no longer
the ‘doctor’, I was their equal.
After my illness, I felt a sense of deep-seated shame and guilt and came to view myself as ‘weak-minded’. This ‘self-stigmatisation’,
where the stigmatised person relates to negative attitudes expressed by others towards themselves and their illness, is debilitating –
if you share in the negativity surrounding you and view such attitudes as ‘understandable’, where is the motivation to fight them?
Other people’s – including my psychiatrist’s – wishes to conceal this episode have only served to compound and perpetuate my own
sense of shame and embarrassment. Of course, they are concerned about my career. My psychiatrist attempted to minimise the
psychotic quality and severity of my illness – does he, too, anticipate discrimination against a fellow doctor with a history of mental
illness?
I am relieved to say that currently I am enjoying a period of sustained mental stability, which I can only hope continues ad infinitum.
So why did I share my experience of psychotic illness? I surmised that all my anti-stigma support for my patients would not mean a
thing unless I was willing to practise as I preach. I would like to think this decision will come to be viewed as one of personal
dedication to the cause of de-stigmatising mental illness, and that the whole experience will help me become a better psychiatrist.
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